key: cord-0970462-k2adgd8n
authors: Miller, Nathaniel L.; Clark, Thomas; Raman, Rahul; Sasisekharan, Ram
title: Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor binding domain
date: 2022-01-24
journal: Cell Rep Med
DOI: 10.1016/j.xcrm.2022.100527
sha: bb610ef7792abc3e120effd46523287465bb1997
doc_id: 970462
cord_uid: k2adgd8n

The Omicron variant features enhanced transmissibility and antibody escape. Here, we describe the Omicron receptor binding domain (RBD) mutational landscape using amino acid interaction (AAI) networks, which are well-suited for interrogating constellations of mutations that function in an epistatic manner. Using AAI, we map Omicron mutations directly and indirectly driving increased escape breadth and depth in class 1-4 antibody epitopes. Further, we present epitope networks for authorized therapeutic antibodies and assess perturbations to each antibody’s epitope. Since our initial modeling following the identification of Omicron, these predictions have been realized by experimental findings of Omicron neutralization escape from therapeutic antibodies ADG20, AZD8895, and AZD1061. Importantly, the AAI predicted escape resulting from indirect epitope perturbations was not captured by previous sequence or point mutation analyses. Finally, for several Omicron RBD mutations we find evidence for a plausible role in enhanced transmissibility via disruption of RBD-down conformational stability at the RBDdown-RBDdown interface.

find evidence for a plausible role in enhanced transmissibility via disruption of RBDdown conformational stability at the RBDdown-RBDdown interface.

The SARS-CoV-2 Omicron (B.1.1.529) variant of concern (VOC) has spread globally due to an apparent fitness advantage over the Delta variant 1 In this study, we analyze the receptor binding domain (RBD) mutational landscape of Omicron using amino acid interaction (AAI) networks 7, 8 . AAI network analysis is particularly well-suited for understanding the impact of constellations of mutations residing within and adjacent to an antibody epitope as occurs on the Omicron variant. For example, AAI network analysis considers how mutation of a residue that does not directly interact with a given antibody paratope (e.g., via a hydrogen bond between side chain and antibody CDR) may still perturb antibody binding if the residue plays a significant structural role in supporting other sites that interact directly with the antibody 8, 9 . Such indirect effects have been conceptualized as mutations outside of the J o u r n a l P r e -p r o o f antibody epitope that alter higher-order protein structure or perturb protein "breathing" [10] [11] [12] . AAI networks quantitate these indirect relationships through which Omicron's mutation constellation may substantially perturb the chemical and physical properties of RBD epitope surfaces. We apply the AAI network lens to map the potential impacts of Omicron RBD mutations on polyclonal antibody responses and therapeutic monoclonal antibodies. We further discuss the limitations in predicting efficacy of therapeutic antibodies against emerging variants based on existing in vitro data for isolated mutations. Finally, we present possible functional roles for Omicron RBD mutations that are not predicted to substantially enhance antibody evasion. Our analysis using a fixedbackbone Omicron homology model and a recently released Omicron spike structure suggests Omicron mutations may modulate RBD-up vs. RBD-down conformational dynamics toward enhanced infectivity.

Toward investigating the antigenic impact of the Omicron RBD mutations, we first mapped direct and indirect effects of Omicron mutations on RBD antibody epitopes using AAI networks. Our RBD epitope map included at least 10 antibodies from each of the four structural classes of anti-RBD antibodies 13 and thus represents the dominant functional components of population-level polyclonal antibody responses 14 . First examining Omicron escape breadth, we found that Omicron mutations occur at RBD sites that interact with all antibodies examined and span the four antibody classes (Figure 1 ). In contrast, our analysis showed that the RBD mutations of the Beta and J o u r n a l P r e -p r o o f Delta variants are confined to sites within class 1 and 2 antibody epitopes, except for Beta N501Y which interacts indirectly with certain class 3 antibodies. This is consistent with experimental evidence documenting Beta escape from class 1 and 2 antibodies 15, 16 and Delta escape primarily from class 2 antibodies 17 . Our analysis therefore suggests that Omicron's increased antibody escape breadth as compared to previous variants is driven by mutations in class 3 and 4 antibody epitopes.

Class 3 antibodies are potent neutralizers that are immunodominant for certain individuals 5 while class 4 antibodies tend to be weakly neutralizing 13 . Our network analysis associated Omicron mutations N440K, G446S, G496S, and Q498R most strongly with enhanced class 3 antibody escape based on these sites having the strongest network interactions with the antibodies surveyed. The RBD of PMS20, a research variant that escapes neutralization from most convalescent and polyclonal sera, features similar class 3 mutations to Omicron at sites 440 and 445, yet also features an R346K mutation that Omicron lacks 18 . Our analysis found that R346 is the most strongly networked residue for certain class 3 antibodies including C135. This suggests that PMS20 may escape more effectively from the class 3 antibody component of sera than Omicron, highlighting a key caveat in comparisons between Omicron and PMS20.

The AAI analysis suggested an additional set of Omicron mutations (G339D, S371L, S373P, S375F) may contribute to class 3 and 4 antibody epitopes via predominantly indirect mechanisms, with mutations at these sites appearing to affect nearly all class 4 antibodies in our panel, as well as select class 3 antibodies including S309, S2M11, C110, CV38-142, Ab 812, and PDI-96. While mutational scanning of J o u r n a l P r e -p r o o f point mutations at these sites suggested these mutations are unlikely to confer significant class 3 and 4 antibody escape in isolation 5 , it is plausible that the combined indirect effects of these four non-conservative mutations could meaningfully alter the local structure in this RBD region and thus perturb class 3 and 4 antibodies. In contrast to escape from class 3 antibodies, however, Omicron lacked mutation at a site that is strongly networked to multiple class 4 antibodies such as 368-9, 377-8, 384, or 434.

Further, we observed that Omicron mutations may enhance escape depth from class 1 antibodies beyond that observed for the Beta variant due to accumulation of additional mutations in class 1 antibody epitopes. The polyclonal antibody response to infection and vaccination has been shown to broaden over the months following exposure due to persistent somatic mutation of antibody CDRs 19 . This broadening process can increase an antibody's tolerance of escape mutations within its epitope 20 , resulting in polyclonal responses with enhanced neutralizing capacity against the Beta variant over time. We found that Omicron has accumulated multiple tightly clustered mutations and therefore may have enhanced escape from matured polyclonal responses that are tolerant of certain class 1 antibody escape mutations such as K417N and N501Y (see Figure 1 ). That is, Omicron's accumulated class 1 mutations may reduce Omicron's susceptibility to class 1 antibodies tolerant of canonical class 1 escape mutations such as K417N. Specifically, Omicron mutations at residues Q493, G496, Q498, and Y505 clustered closely with the Beta and Omicron escape mutations at residues K417 and N501 indicating class 1 escape depth. Such escape depth could have contributed to PMS20's escape from convalescent and vaccinee sera 18 , as it can be seen in Figure 1 that PMS20 also features multiple class 1 mutations. Notably, J o u r n a l P r e -p r o o f however, PMS20 was shown not to fully escape from polyclonal responses generated from infection followed by vaccination 18 , suggesting that Omicron's class 1 escape depth and class 3 escape breadth alone may not confer this ability.

We subsequently applied AAI networks to examine the Omicron mutations in the context of their ability to evade neutralization by therapeutic antibodies of current clinical relevance (Figure 2 ). An important perspective offered by our network approach is the impact of mutations that are not directly located at the interface of antibody-antigen complexes, yet may still disrupt the antibody interaction. Specifically, it is important to consider the allosteric effects of the many Omicron mutations and how they may cooperatively affect antibody binding to the Omicron RBD by modulating the structural and chemical features of the epitope surface. Our results present an accessible and concise visualization of the network interactions between RBD sites mutated on Omicron and authorized therapeutic antibodies.

We found that Omicron mutations occur at sites that are strongly directly 

Given the substantial transmission advantage of Omicron over Delta, it is plausible that Omicron RBD mutations contribute to enhanced transmission by mechanisms other than or in addition to antibody escape. Above (Figure 1) , we identified several Omicron mutations that do not appear to play a major role as polyclonal epitope constituents or whose predicted contribution to antibody evasion is unlikely to confer a substantial fitness advantage due to the mutations occurring in class Omicron variant at these three sites and may also include additional Omicron mutations.

Using AAI networks to examine the local residue dependencies in this vicinity, we observed a network extending from the known synergistic pair 498+501 to position 505, suggesting Omicron H505 may modulate the synergistic ACE-2 binding effect for Q498R + N501Y.

RBD-RBD Interface Stability: While Omicron's mutations at sites 371, 373, and 375 may contribute to escape from class 3 and 4 antibodies, evolution of such a triplet mutation toward this escape function is not parsimonious given that other single mutations have been previously identified as conferring greater class 3 and 4 antibody escape 5 . We therefore hypothesized that mutations S371L, S373P, and S375F might provide a fitness advantage other than or in addition to escape. To test this hypothesis, we sought 

The network-based analysis of the Omicron mutational landscape presented here describes Omicron's escape breadth and depth. We find evidence for enhanced escape breadth of Omicron as compared to the Beta and Delta variants due primarily to J o u r n a l P r e -p r o o f class 3 escape mutations as well as increased escape depth within class 1 epitopes.

We further identify plausible class 4 antibody escape via the mutations at sites 371, 373, and 375 which may alter class 4 epitope surfaces indirectly, but note that escape from class 4 antibodies is unlikely to confer a meaningful escape fraction from sera and additionally that these sites are not the dominant class 4 escape sites. Additionally, clades of Omicron bearing R346K/S should be monitored closely 23 Together these data bode well for preservation of protection from severe disease provided by vaccination and convalescence. However, early evidence suggests that 30% (CD8) and 45% (CD4) of immunocompromised individuals (those receiving anti-CD20 therapy in the study) do not maintain detectable T-cell response against Omicron even following a booster vaccine dose 44 . This finding therefore highlights the critical J o u r n a l P r e -p r o o f need to extend additional resources to protect vulnerable populations from Omicron and future VOC. These results from immunocompromised individuals also provide evidence that vaccine boosters may enhance the frequency and potency of T-cell responses against Omicron, wherein T-cell breadth has previously been associated with mild disease courses 45 .

Further, it will be important to determine if the accumulation of class 1 escape mutations, which provide escape depth, reads through to a meaningful escape impact or reduction in vaccine efficacy. Thus far, such depth seems to provide little additional escape benefit given that the combination of K417 and N501 mutations appears sufficient to escape from class 1 antibodies in most convalescent and vaccine sera 46 .

However, it is notable that the PMS20 variant was unable to fully escape from polyclonal responses generated by infection followed by vaccination 18 In light of probable continued Omicron dominance, determining the various functional roles of the Omicron mutations is critical. In particular, it is important to understand the complex relationships between Omicron mutations, and the contribution of these indirect effects to Omicron's antibody escape and enhanced transmissibility.

Network-based approaches such as those presented in this study are particularly well suited for modeling such indirect interactions.

Limitations of our study include (1) sampling a representative polyclonal response from a set of individual antibodies and nanobodies at sufficient resolution, (2) performing Omicron analyses based on antibody interactions with wild-type SARS-CoV-2, and (3) the lack of a structural model of the Omicron spike in the 3 RBD-down conformation.

We limit the impact of (1) by sampling at least 10 antibodies from each of the four major anti-RBD antibody classes, and observe a high degree of similarity between antibodies suggesting these samples span the dominant epitope-paratope interactions for each class. Further, AAI network analysis is somewhat less sensitive to structural resolution than traditional structural analysis that rely heavily on interpretation of specific bonds. Together, these data and the data on RaTG13 vs. SARS-CoV-2 from Wrobel et al. 31 , support our hypothesis and warrant further investigation of Omicron mutations at RBDdown-RBDdown interface.

NLM was supported in part by T32 ES007020/ES/NIEHS NIH and by SMART, Singapore.

N.L.M. and T.C. conducted the analyses; all authors designed the analyses and wrote the paper.

RS is a board member of Tychan Pte. Ltd Singapore, which focuses on Infectious Diseases.

J o u r n a l P r e -p r o o f Introducing an indirect networking metric that accounts for indirect interactions successfully identifies the Omicron-AZD1061 escape. The combination of both direct and indirect terms in total networking is highly consistent with experimental observations. 

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Ram Sasisekharan (rams@mit.edu).

 This study did not generate new unique reagents.

 This paper analyzes existing, publicly available data. These accession numbers for the datasets are listed in the key resources table.  All original code has been deposited at GitHub and is publicly available as of the date of publication.

DOIs are listed in the key resources table. Additional Supplemental Items are available from Github/Zenodo at http://dx.doi.org/10.5281/zenodo.5865881  Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

Structural data generated experimentally by others describing epitope-paratope interactions between antibodies/nanobodies and recombinant spike protein or the spike RBD was analyzed. The antibodies/nanobodies analyzed are listed in supplemental table S1. Table S1 additionally includes Protein Data Bank accession codes for the structural model corresponding to each antibody/nanobodywhere further experimental details for each structure determination are available-and DOIs for the accompanying publications describing biological experimental details such as production and purification of each antibody.

Amino Acid Interaction (AAI) Network: AAI networks were quantified as described in the QUANTIFICATION AND STATISTICAL ANALYSIS section. The quantification includes definition of Direct, Indirect, and Total networking metrics which are referenced in the below methods subsections. (Figures 1 and 2) : Total networking scores between each RBD site and the entirety of the antibody or nanobody paratope and framework regions were computed and normalized as described above. Subsequently, these data were aggregated into a single matrix describing the network interactions between all antibodies (Table S1 ) and all RBD sites. This matrix was then plotted as a heatmap and clustered using clustermap from the Seaborn statistical data visualization package 48 . Dendrograms were generated for RBD sites (rows) and antibodies (columns) using the 'canberra' distance metric. For quantifying potential networking perturbations between individual therapeutic antibodies and variants of concern such as Omicron, the total networking between the given antibody and all RBD sites mutated on the given variant was summed to obtain a single value. Repeating this process for a panel of antibodies and a panel of variants results in computation of a refined AAI network matrix, which was subsequently visualized as a clustered heatmap using clustermap as described above. Note that the heatmap in Figure 1 was manually annotated with vertical dotted lines and labels for each antibody class designation, as well as arrows indicating the mutations for each variant shown on the right-side. The surface representations of RBD were constructed in PyMOL. Note that Figure 2 is a composite of three heatmaps, in which the only modification of the output is that two of the three identical color maps (legends) are removed for clarity. (Figures S1-4) : AAI networks were visualized for certain therapeutic antibodies as second-and third-order networks as follows. First, the set of all RBD sites that are networked to the given antibody paratope or framework regions was computed. These sites, which interact directly with the given antibody, form the core of the interaction network between the antibody and RBD. Next, all RBD sites that are networked to first layer of sites was computed. Both sets of RBD sites were combined and used to build a network using NetworkX 49 , wherein RBD sites were defined as nodes and edges were constructed between all pairs of RBD sites with non-zero networking and weighted according to AAI networking strength. Node positions were computed from these edge weights using the Fruchterman-Reingold force-directed algorithm as implemented in NetworkX spring_layout with the optimal node distance defined as 10 times the inverse square root of the network order, such that pairs of RBD sites that are strongly networked appear as nodes that are tightly-clustered and separated by a short edge. Finally, all nodes and edges were plotted, with nodes assigned colors based on whether they are directly or indirectly networked to the antibody paratope/framework, and whether or not they are mutated on the Omicron variant. In the case of antibody ADG2, in which no structure is publicly available and so RBD sites directly networked to the antibody cannot be determined algorithmically, the four "critical" epitope sites 405, 502, 504, and 505 reported in Rappazzo et al. 28 were chosen as the first directly-networked set or the network "core". Four directly-networked sites is fewer than is typically observed for antibodies suggesting that additional RBD residues are likely involved in direct interactions with the antibody. To ensure that we captured all RBD sites that may be indirectly networked to antibody ADG2 in our network visualization, we therefore added an additional network layer to the epitope network for ADG2. That is, we followed the same workflow described above for the other antibody networks, but included an additional degree of indirect networking such that the ADG2 network is represented as: four critical sites  first layer of indirectly networked sites  second layer of indirectly networked sites. Note that legends were manually annotated on top of the raw network figures for all four supplemental figures.

Omicron RBDdown-RBDdown Interface Analysis (Figure 3) : A fixed-backbone model was used to analyze the Omicron RBDdown-RBDdown interface mutations in the 3-RBD down conformation, as homology modeling is limited in its ability to accurately predict RBD structure in the context of 15 Omicron RBD mutations, particularly for probable backbone perturbations conferred by mutations such as S373P that reside within the specific interface in question. The fixed-backbone approximation offers initial insight into whether or not mutations in the RBDdown-RBDdown interface could result in structural alterations and divergent conformational preferences in the Omicron spike trimer. First, a homology model of the Omicron RBDdown-RBDdown interface was constructed via SWISS-Model 50 using the 6ZGI 31 template. Subsequently, with the backbone fixed, all side chains within 30 Å heavy atom distance from site 505 were repacked on the two RBD protomers of the homology model in PyRosetta 51 . This repacking process was also performed for the SARS-CoV-2 wild-type (WT) template (6ZGI) as a control. Finally, the Omicron and WT RBDdown-RBDdown interfaces were analyzed using PDBePISA 52 , which reports dG values at each site for the WT and Omicron RBDdown-RBDdown interfaces as well as buried surface area for the interface. Surface complementarity was computed using the InterfaceAnalzyerMoveer in PyRosetta according to the sc_value metric. Interfaces visualizations were generated using PyMOL 53 . For analysis of the 1 RBD-up Omicron spike structure, the RBDdown-RBDdown interface was first obtained from PDBs 6XM3 34 and 7TB4 33 . For interface analysis, both WT and Omicron RBDdown-RBDdown interfaces were analyzed using PDBePISA as above to report buried surface area. For visualization in Figure 3B , protomer 1 was assigned to the RBD monomer most distal from the RBDup for both WT and Omicron, and both promoter 1 were aligned in PyMOL. For Figure 3B , the three hydrogen bonds shown for the WT interface were consistently identified by both PDBePISA and PyMOL. Note that the red arrows indicating the 7-10 Å shift, the mutation labels and ΔΔG values, and the promoter labels were manually annotated.

Amino Acid Interaction (AAI) Network Quantification: For each antibody-RBD complex, AAI network scores between every pair of residues within the complex were computed 7, 8 . Network scores quantify all contacts for both side-chain and backbone atoms between residues, and weight these contacts according to the energetics of the expected interaction based on experimental energetic measurements for each interaction type. The following interactions are quantified: hydrogen bonds, pi bonds, disulfide bonds, polar interactions, salt bridges, and Van der Waals interactions. The following metrics were defined and computed for all surveyed structures from the resulting interaction network. Direct Networking: For a given residue on RBD, the sum of all interactions between the RBD residue and all residues on the complexed antibody/nanobody including both the paratope and framework regions. Indirect Networking: For a given residue on RBD, the sum of all interactions between the RBD residue and all other residues on RBD which have non-zero direct networking to the given antibody/nanobody's paratope or framework region. Given that the AAI network is weighted more heavily toward interactions involving at least one side-chain as compared to backbone interactions, an additional computation was performed for the indirect networking scores for glycine residues. Specifically, glycine indirect networking was interpolated from nearby residues (within 5Å of the glycine alpha carbon) based on averaging the network connections from these adjacent residues to their partners. Total Networking: For a given residue on RBD, the sum of direct and indirect networking scores for the residue. Note that for all networking metrics, scores are normalized to the highest networking score within each RBD-mAb complex. Structures analyzed and their PDB identifiers are listed in Supplementary Table S1 .The raw networking matrices from which direct, indirect, and total networking are computed are available in the Key Resources Table, along with additional software packages 54-56 required for the described computation.

Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. bioRxiv : the preprint server for biology

The N501Y spike substitution enhances SARS-CoV-2 transmission

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape

Networks link antigenic and receptorbinding sites of influenza hemagglutinin: Mechanistic insight into fitter strain propagation

An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants

A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein

Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41

Antigenic drift: Understanding COVID-19

Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Structural basis of a shared antibody response to SARS-CoV-2

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies

High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2. bioRxiv

Regeneron Evaluating REGEN-COV® and Next Generation Antibodies against New Omicron COVID-19 Variant. 1-8

Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2. bioRxiv

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against Omicron SARS-CoV-2 Variant . Press Release

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects

The SARS-CoV-2 spike protein: balancing stability and infectivity

RCSB PDB -7TB4: Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern

Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains

Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures

Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody: mechanisms for the high infectivity, immune evasion and antibody drug discovery

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants

SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron

Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19

Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron

seaborn: statistical data visualization

Exploring Network Structure, Dynamics, and Function using NetworkX | BibSonomy

SWISS-MODEL: homology modelling of protein structures and complexes

PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta

Inference of macromolecular assemblies from crystalline state

The PyMOL Molecular Graphics System. Version 2.0 Schrödinger, LLC

Data Structures for Statistical Computing in Python

Matplotlib: A 2D graphics environment

Array programming with NumPy